These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29858385)

  • 1. Repopulating hematopoietic stem cells from steady-state blood before and after
    Lapostolle V; Chevaleyre J; Duchez P; Rodriguez L; Vlaski-Lafarge M; Sandvig I; Brunet de la Grange P; Ivanovic Z
    Haematologica; 2018 Oct; 103(10):1604-1615. PubMed ID: 29858385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells.
    Yao CL; Feng YH; Lin XZ; Chu IM; Hsieh TB; Hwang SM
    Stem Cells Dev; 2006 Feb; 15(1):70-8. PubMed ID: 16522164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates.
    Mahmud N; Patel H; Hoffman R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):681-90. PubMed ID: 15389434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells.
    Hess DA; Wirthlin L; Craft TP; Herrbrich PE; Hohm SA; Lahey R; Eades WC; Creer MH; Nolta JA
    Blood; 2006 Mar; 107(5):2162-9. PubMed ID: 16269619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term repopulating hematopoietic stem cells and "side population" in human steady state peripheral blood.
    Brunet de la Grange P; Vlaski M; Duchez P; Chevaleyre J; Lapostolle V; Boiron JM; Praloran V; Ivanovic Z
    Stem Cell Res; 2013 Jul; 11(1):625-33. PubMed ID: 23651585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stromal-free, serum-free system to expand ex vivo hematopoietic stem cells from mobilized peripheral blood of patients with hematologic malignancies and healthy donors.
    Yao CL; Hsu SC; Hwang SM; Lee WC; Chiou TJ
    Cytotherapy; 2013 Sep; 15(9):1126-35. PubMed ID: 23768928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD34(+)CXCR4(-) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation.
    Kollet O; Petit I; Kahn J; Samira S; Dar A; Peled A; Deutsch V; Gunetti M; Piacibello W; Nagler A; Lapidot T
    Blood; 2002 Oct; 100(8):2778-86. PubMed ID: 12351385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential study on the in vivo homing potential of human hematopoietic stem/progenitor cells from different sources in xenotransplanted NOD/SCID mouse model].
    Yang Z; Lu SH; Li YH; Liu B; Wang HJ; Jia HR; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):391-5. PubMed ID: 17939405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of ex vivo expanded CD34
    Zhang Y; Shen B; Guan X; Qin M; Ren Z; Ma Y; Dai W; Ding X; Jiang Y
    Stem Cell Res Ther; 2019 Jun; 10(1):173. PubMed ID: 31196160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice.
    Foguenne J; Di Stefano I; Giet O; Beguin Y; Gothot A
    Haematologica; 2009 Feb; 94(2):185-94. PubMed ID: 19144663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells.
    Leung KT; Chan KY; Ng PC; Lau TK; Chiu WM; Tsang KS; Li CK; Kong CK; Li K
    Blood; 2011 Feb; 117(6):1840-50. PubMed ID: 21063023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions.
    Lapidot T
    Ann N Y Acad Sci; 2001 Jun; 938():83-95. PubMed ID: 11458529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein.
    Suzuki T; Yokoyama Y; Kumano K; Takanashi M; Kozuma S; Takato T; Nakahata T; Nishikawa M; Sakano S; Kurokawa M; Ogawa S; Chiba S
    Stem Cells; 2006 Nov; 24(11):2456-65. PubMed ID: 16857897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of multipotent CD133(+)CD45RA(-)CD34(+) hematopoietic stem cells is not increased in fetal liver compared with adult stem cell sources.
    Radtke S; Haworth KG; Kiem HP
    Exp Hematol; 2016 Jun; 44(6):502-7. PubMed ID: 27016273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex Vivo Expansion of CD34
    Bari S; Zhong Q; Fan X; Poon Z; Lim AST; Lim TH; Dighe N; Li S; Chiu GNC; Chai CLL; Hwang WYK
    Stem Cells Transl Med; 2018 May; 7(5):376-393. PubMed ID: 29392885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of expression of CXCR4 and adhesion molecules by human CD34+ cells from different sources: role in homing efficiency in NOD/SCID mice.
    Herrera C; Sanchez J; Torres A; Pascual A; Rueda A; Alvarez MA
    Haematologica; 2004 Sep; 89(9):1037-45. PubMed ID: 15377464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11.
    Albella B; Segovia JC; Guenechea G; Pragnell IB; Bueren JA
    Transplantation; 1999 May; 67(10):1348-57. PubMed ID: 10360589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient ex vivo expansion of NOD/SCID-repopulating cells with lympho-myeloid potential in hematopoietic grafts of children with solid tumors.
    Tourino C; Pflumio F; Novault S; Massé A; Guiller M; Bonnet ML; Valteau-Couanet D; Hartmann O; Vainchenker W; Beaujean F; Coulombel L; Turhan AG
    Hematol J; 2001; 2(2):108-16. PubMed ID: 11424003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.